97307 ⎘
Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
INTERLEUKIN-21 RECEPTOR BINDING PROTEINS
#11402Compositions and methods for the therapy and diagnosis of cytomegalovirus infections
#11403ANTI-CXCL9, ANTI-CXCL10, ANTI-CXCL11, ANTI-CXCL13, ANTI-CXCR3 AND ANTI-CXCR5 AGENTS FOR INHIBITION OF INFLAMMATION
#11404Humanized anti-FGF19 antagonists and methods using same
#11405MULTI-DIMENSIONAL SELECTION OF PROTEIN MUTANTS USING HIGH THROUGHPUT SEQUENCE ANALYSIS
#11406Antibodies Directed to Angiopoietin-1 and Angiopoietin-2 and Uses Thereof
#11407Generation of anti-FN14 monoclonal antibodies by ex-vivo accelerated antibody evolution
#11408Anti-fibroblast activation protein antibodies and methods and uses thereof
#11409ANTIBODIES AGAINST HUMAN CCN1 AND USES THEREOF
#11410Antibodies that bind TGF-alpha and epiregulin
#11411Dual Variable Domain Immunoglobulins and Uses Thereof
#11412Agents, uses and methods
#11413Method of treating rheumatoid arthritis with an anti-IL-6R antibody
#11414Methods for treating conditions associated with MASP-2 dependent complement activation
#11415Optimized Fc Variants
#11416COMPOSITIONS AND METHODS FOR TREATING DISEASES OF PROTEIN AGGREGATION INVOLVING IC3B DEPOSITION
#11417Treatment of tumors using specific anti-L1 antibody
#11418Monoclonal thyroid stimulating or blocking antibodies, peptide sequences corresponding to their variable regions, and their uses in diagnostic, preventive and therapeutic medicine
#11419STEM CELL TARGETING
#11420ANTIBODY MOLECULES THAT BIND TO IL-6 RECEPTOR
#11421Antibody-drug conjugates
#11422Antibodies against T cell immunoglobulin domain and mucin domain 1 (TIM-1) antigen and uses thereof
#11423Crystalline anti-hTNFalpha antibodies
#11424Methods of treating psoriasis using IL-17 receptor A antibodies
#11425ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)
#11426Dual Variable Region Antibody-Like Binding Proteins Having Cross-Over Binding Region Orientation
#11427STABILIZED SINGLE DOMAIN ANTIBODIES
#11428ANTI-ALPHA V BETA 6 ANTIBODIES
#11429Antibody Fc variants
#11430Anti-CEA antibodies
#11431Antibody targeting osteoclast-related protein Siglec-15
#11432Human anti-IL-23 antibodies, compositions, methods and uses
#11433Neuropilin antagonists
#11434Monoclonal antibody against human HIG-1 polypeptide
#11435Cytotoxic benzodiazepine derivatives
#11436ANTIBODIES TO M-CSF
#11437NEUTRALIZING ANTIBODIES TO HIV-1 AND THEIR USE
#11438Biological materials related to c-Met
#11439BISPECIFIC BINDING AGENTS TARGETING IGF-1R AND ERBB3 SIGNALLING AND USES THEREOF
#11440CROSS-SPECIES-SPECIFIC BISPECIFIC BINDERS
#11441Antagonist antibodies and their fab fragments against GPVI and uses thereof
#11442Anti-interferon-α antibodies
#11443antibodies and uses thereof
#11444Antigen associated with rheumatoid arthritis
#11445Human monoclonal antibodies against CD25
#11446Methods of preparation of conjugates
#11447Diagnostic antibody assay
#11448Human tissue factor antibody and uses thereof
#11449Neutralizing antibodies to HIV-1 and their use
#11450Compositions and methods for increasing muscle growth
#11451ANTI-TROP-2 ANTIBODY
#11452Compositions and methods relating to anti-IGF-1 receptor antibodies
#11453VASCULAR ENDOTHELIAL CELL GROWTH FACTOR ANTAGONISTS AND USES THEREOF
#11454Anti-NKG2A antibodies and uses thereof
#11455Monovalent Antigen Binding Proteins
#11456Dual FC antigen binding proteins
#114574-1BB binding molecules
#11458Monoclonal antibodies and single chain antibody fragments against cell-surface prostate specific membrane antigen as diagnostic and therapeutic tools for prostate cancer
#11459Anti-VEGF monoclonal antibody and pharmaceutical composition comprising said antibody
#11460Anti-C5a binding antibodies with high block activity
#11461ANTI-ORAI1 ANTIGEN BINDING PROTEINS AND USES THEREOF
#11462AX1 PCSK9 antagonists
#11463IP-10 antibodies and their uses
#11464Humanized antibodies against human IL-22RA
#11465Antibody targeting osteoclast-related protein siglec-15
#11466Methods for treating conditions associated with c-fms
#11467Humanized anti-factor D antibodies and uses thereof
#11468High concentration formulations of anti-C5 antibodies
#11469CH2 domain template molecules derived from rational grafting of donor loops onto CH2 scaffolds
#11470Optimized Fc variants and methods for their generation
#11471TNF-α binding proteins
#11472METHOD OF TARGETING SPECIFIC CELL POPULATIONS USING CELL-BINDING AGENT MAYTANSINOID CONJUGATES LINKED VIA A NON-CLEAVABLE LINKER, SAID CONJUGATES AND METHODS OF MAKING SAID CONJUGATES
#11473Non-naturally occurring T cell receptors
#11474Immuno-based botulinum toxin serotype A activity assays
#11475Binding molecules to the human OX40 receptor
#11476VIRAL POLYPEPTIDES AND METHODS
#11477VEGF-BINDING MOLECULES
#11478Methods for treating visceral pain by administering antagonist antibodies directed against calcitonin gene-related peptide
#11479Anti-IL-6 receptor antibodies and methods of use
#11480Antigen binding proteins
#11481Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses
#11482Anti-mesothelin antibodies and immunoconjugates
#11483Engineered anti-TSLP antibody
#11484Human antibodies that bind human TNFα
#11485Fibroblast growth factor receptor-3 (FGFR-3) inhibitors and methods of treatment
#11486Fc region-containing polypeptides that exhibit improved effector function due to alterations of the extent of fucosylation, and methods for their use
#11487Humanized anti-TNFα antibodies
#11488Methods of treatment by administering antibodies that bind colony stimulating factor 1 receptor (CSF1R)
#11489Anti-IL13 antibodies and uses thereof
#11490ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)
#11491Notch1 binding agents and methods of use thereof
#11492Antibodies to granulocyte-macrophage colony-stimulating factor
#11493Antibodies against human IL33R and uses thereof
#11494ANTIBODIES THAT BIND HUMAN CD27 AND USES THEREOF
#11495Humanized anti-beta7 antagonists and uses therefor
#11496Engineered immunoglobulin FC polypeptides
#11497Nucleic acids encoding human anti-kir antibodies
#11498Modified antibody compositions, methods of making and using thereof
#11499Antibodies against human tweak and uses thereof
#11500Anti-EPHB4 antibodies and methods using same
#11501Modified Variable Domain Molecules And Methods For Producing And Using Same
#11502DRG11-responsive (dragon) polypeptides
#11503DRG11-responsive (DRAGON) gene family
#11504ANIMAL MODELS AND THERAPEUTIC MOLECULES
#11505SINGLE DOMAIN ANTIBODIES DIRECTED AGAINST TUMOR NECROSIS FACTOR-ALPHA AND USES THEREFOR
#11506Construction of diverse synthetic peptide and polypeptide libraries
#11507Antibodies to IL-6 and their uses
#11508PREVENTION AND TREATMENT OF SYNUCLEINOPATHIC AND AMYLOIDOGENIC DISEASE
#11509HUMAN ANTIBODIES THAT BIND HUMAN IL-12 AND METHODS FOR PRODUCING
#11510Antibodies that specifically bind to the EphA2 receptor
#11511Anti-CD38 antibodies
#11512Anti-RANTES antibodies
#11513Treatment of osteoarthritis and pain
#11514Plasma kallikrein binding proteins
#11515Cytotoxicity Mediation of Cells Evidencing Surface Expression of CD44
#11516HALF IMMUNOGLOBULIN BINDING PROTEINS AND USES THEREOF
#11517Expandable liquid volume in an LED bulb
#11518Antibodies against a proliferating inducing ligand (APRIL) and methods of use thereof
#11519Anti-alpha5/beta1 antibody
#11520Method of treating a malignant tumor by administering antibodies directed to DLL4
#11521METHOD TO TREAT USING ANTAGONISTIC ANTI-hTNFSF13B HUMAN ANTIBODIES
#11522Compositions and Methods for Binding Lysophosphatidic Acid
#11523TRI-VARIABLE DOMAIN BINDING PROTEINS AND USES THEREOF
#11524Human domain antibodies against components of the human insulin-like growth factor (IGF) system
#11525Immunoglobulin molecules with improved characteristics
#11526Carrier immunoglobulins
#11527GENERATION, CHARACTERIZATION AND USES THEREOF OF ANTI-HER3 ANTIBODIES
#11528Common Light Chain Mouse
#11529Preparation of isolated agonist anti-EDAR monoclonal antibodies
#11530METHOD OF ACQUIRING PROTEINS WITH HIGH AFFINITY BY COMPUTER AIDED DESIGN
#11531Antigen binding proteins capable of binding thymic stromal lymphopoietin
#11532Sp35 antibodies and uses thereof
#11533Anti-GITR antibodies
#11534Methods for Treating or Preventing Malaria by Administering an Antibody that Specifically Binds Angiopoietin-2 (Ang-2)
#11535ANTI-KIT ANTIBODIES AND USES THEREOF
#11536Bispecific EGFRvIII x CD3 antibody engaging molecules
#11537Anti-IL-6 antibodies for the treatment of oral mucositis
#11538Detection of amyloid deposits using anti-amyloid antibodies
#11539ANTI-CD38 HUMAN ANTIBODIES AND USES THEREOF
#11540SUPERIOR EFFICACY OF CD37 ANTIBODIES IN CLL BLOOD SAMPLES
#11541Anti-TIM-3 antibody
#11542Anti-CD19 antibodies
#11543Dual variable domain immunnoglobulins and uses thereof
#11544IL3Rα antibody conjugates and uses thereof
#11545Antibodies against extended type 1 chain antigens, derivatives thereof and use
#11546Methods for the generation of multispecific and multivalent antibodies
#11547DNA encoding antibody molecules having specificity for human IL-6
#11548Fully human antibodies to BTLA
#11549Alpha-4-beta-7 heterodimer specific antagonist antibody
#11550Antibody molecules which bind IL-17A and IL-17F
#11551KIDNEY DISEASE TARGETS AND USES THEREOF
#11552Chemokine receptor binding polypeptides
#11553MEASUREMENT OF ANTI-AMYLOID ANTIBODIES IN HUMAN BLOOD
#11554Specific binding proteins and uses thereof
#11555Screening strategies for the identification of binders
#11556TARGETING TISSUE FACTOR TO ACTIVATED PLATELETS
#11557DRG11-responsive (DRAGON) gene family
#11558Erythrocyte-binding therapeutics
#11559Screening of protein candidates
#11560Human antibodies that bind human TNFα and methods of using same
#11561ANTI-TGF-BETA RECEPTOR II ANTIBODIES
#11562Therapeutic Monoclonal Antibodies that Neutralize Botulinum Neurotoxins
#11563Alpha-4-beta-7 heterodimer specific antagonist antibody
#11564Bispecific binding agents for modulating biological activity
#11565Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide
#11566Meditopes and related meditope-monoclonal antibody delivery systems, synthesis and therapeutic uses thereof
#11567Methods of Treating Pediatric Acute Lymphoblastic Leukemia with an Anti-CD22 Immunotoxin
#11568FUNCTIONAL HEAVY CHAIN ANTIBODIES, FRAGMENTS THEREOF, LIBRARY THEREOF AND METHODS OF PRODUCTION THEREOF
#11569Anti-ADDL antibodies and uses thereof
#11570High affinity antibodies that neutralize enterotoxin B
#11571Monoclonal antibodies against ANGPTL4
#11572Nogo-A binding molecules and pharmaceutical use thereof
#11573Nanobody against IL-6R
#11574Binding members for interleukin-4 receptor alpha (IL-4Ra) - 173
#11575Monoclonal antibodies that neutralize anthrax toxins
#11576LOW AFFINITY BLOOD BRAIN BARRIER RECEPTOR ANTIBODIES AND USES THEREFOR
#11577ANIMAL MODELS AND THERAPEUTIC MOLECULES
#11578High affinity human antibodies to human nerve growth factor
#11579Interleukin-1 Alpha Antibodies and Methods of Use
#11580Antibodies For Oncogenic Strains Of HPV And Methods Of Their Use
#11581Humanised antibodies to toll-like receptor 2 and uses thereof
#11582Anti-ADDL monoclonal antibody and use thereof
#11583Anti-IL13 antibodies and uses thereof
#11584Methods of treating cancer with human monoclonal antibodies against interleukin 8
#11585Methods of preventing or treating pain using anti-NGF antibodies that selectively inhibit the association of NGF with TrkA, without affecting the association of NGF with p75
#11586Means and methods for producing high affinity antibodies
#11587Velocity factor
#11588Methods and compositions for inhibiting CD32B expressing cells
#11589EGFR-binding molecules and immunoconjugates thereof
#11590Methods and compositions for inhibiting CD32B expressing cells
#11591C-Met antibody combinations
#11592Anti-IL13 antibodies and uses thereof
#11593Humanized antibodies specific for HSP65-derived peptide-6 methods and uses thereof
#11594Antibodies against IL-18R1 and uses thereof
#11595Human-murine chimeric antibodies against respiratory syncytial virus
#11596ANTI-JAM-A ANTIBODIES
#11597COMPOSITIONS AND METHODS FOR DETECTING OR ELIMINATING SENESCENT CELLS TO DIAGNOSE OR TREAT DISEASE
#11598Antibodies
#11599Soluble “heavy-chain only” antibodies
#11600BISPECIFIC ANTI-EGFR/ANTI-IGF-1R ANTIBODIES
#11601Modified antibody compositions, methods of making and using thereof
#11602Anti c-Met antibodies
#11603Anti-CD79B antibodies and immunoconjugates and methods of use
#11604BACE1 antibodies
#11605Neutralizing anti-CCL20 antibodies
#11606Engineered anti-IL-23R antibodies
#11607Methods and compositions for inhibiting CD32b expressing cells
#11608Compositions and methods for the diagnosis and treatment of immune disorders
#11609Antibodies
#11610Anti-NGF compositions and use thereof
#11611Prevention and Treatment of Synucleinopathic and Amyloidogenic Disease
#11612Antibodies against human angiopoietin 2
#11613GLYCOSYLATED MAMMALIAN NGAL AND USE THEREOF
#11614Antibodies against human angiopoietin 2
#11615Specific binding agents of human angiopoietin-2
#11616Fully human antibodies against human 4-1BB
#11617Anti-IL-17A/IL-17F cross-reactive antibodies
#11618Human monoclonal antibody
#11619Methods of preventing or treating pain using anti-NGF antibodies
#11620Methods of preventing inflammation and treating pain using anti-NGF compositions
#11621High affinity human antibodies to human IL-4 receptor
#11622Methods and compositions for targeting polyubiquitin
#11623ULTRA HIGH AFFINITY NEUTRALIZING ANTIBODIES
#11624ANTI-TNF-a ANTIBODIES AND THEIR USES
#11625Antibodies to matrix metalloproteinase 9
#11626Monoclonal antibodies to fibroblast growth factor receptor 2
#11627POLYPEPTIDES WITH ENHANCED ANTI-INFLAMMATORY AND DECREASED CYTOTOXIC PROPERTIES AND RELATING METHODS
#11628POLYPEPTIDES, ANTIBODY VARIABLE DOMAINS & ANTAGONISTS
#11629Ligands that bind TGF-β receptor RII
#11630Design and construction of diverse synthetic peptide and polypeptide libraries
#11631METHODS FOR PRODUCING MEMBERS OF SPECIFIC BINDING PAIRS
#11632DNA encoding antibody molecules which bind human IL-17
#11633Cancer specific antibody and cell surface proteins
#11634Human cytomegalovirus neutralizing antibodies and use thereof
#11635Human cytomegalovirus neutralizing antibodies and use thereof
#11636ANTI-IL-23 IMMUNOGLOBULINS
#11637Conserved Hemagglutinin Epitope, Antibodies to the Epitope and Methods of Use
#11638Human antibodies to the human glucagon receptor and methods of use thereof
#11639MUC1 antibodies
#11640Anti-FGF19 antibodies and methods using same
#11641C3b antibodies and methods for the prevention and treatment of complement-associated disorders
#11642NEUTRALIZING MOLECULES TO INFLUENZA VIRUSES
#11643Monovalent, bivalent and trivalent anti human respiratory syncytial virus (HRSV) nanobody constructs for the prevention and/or treatment of respiratory tract infections
#11644Anti-IL-6 antibodies for the treatment of anemia
#11645Anti-FAP antibodies and methods of use
#11646Immuno-based botulinum toxin serotype A activity assays
#11647Anti-antibodies and methods of use
#11648Methods and compositions for bi-specific targeting of CD19/CD22
#11649Fusion antibodies for HIV therapy
#11650BISPECIFIC ANTI-HER ANTIBODIES
#11651SELECTIVE AND POTENT PEPTIDE INHIBITORS OF Kv1.3
#11652Anti-AXL antibody
#11653ANTIBODIES AS T CELL RECEPTOR MIMICS, METHODS OF PRODUCTION AND USES THEREOF
#11654ACTRIIA BINDING AGENTS AND USES THEREOF
#11655Humanized AXL antibodies
#11656Composition of anti-ENDO180 antibodies and methods of use for the treatment of cancer and fibrotic diseases
#11657TARGETED BINDING AGENTS DIRECTED TO a5BETA1 AND USES THEREOF
#11658Human monoclonal antibodies against protective antigen
#11659Antibodies for guanylyl cyclase receptors
#11660Human Monoclonal Antibody Specific for Lipopolysaccharides (LPS) of Serotype IATS 01 of Pseudomonas Aeruginosa
#11661Human antibodies to human TNF-like ligand 1A (TL1A)
#11662ANTI-PAI-1 ANTIBODIES AND METHODS OF USE THEREOF
#11663Anti-serum albumin single variable domains
#11664Aβ binding molecules
#11665Recombinant IL-9 antibodies and uses thereof
#11666TARGETED BINDING AGENTS DIRECTED TO UPAR AND USES THEREOF
#11667Optimized monoclonal antibodies against tissue factor pathway inhibitor (TFPI)
#11668Antibodies binding human collagen II
#11669Anti-mesothelin antibodies
#11670ANTAGONISTS, USES & METHODS FOR PARTIALLY INHIBITING TNFR1
#11671IL-17 antibodies
#11672Antibodies for epidermal growth factor receptor 3 (HER3)
#11673Method for treating breast cancer using antibody binding to MMP-14
#11674MOUSE MODELS
#11675Amatoxin-armed therapeutic cell surface binding components designed for tumour therapy
#11676Anti-TAT226 antibodies and immunoconjugates
#11677Anti CEACAM1 antibodies and methods of using same
#11678Methods for treating B-cell lymphoma by administering an anti-CD20 antibody
#11679STABILIZED FC POLYPEPTIDES WITH REDUCED EFFECTOR FUNCTION AND METHODS OF USE
#11680CD86 antagonist multi-target binding proteins
#11681Humanized anti-IL-18 antibodies
#11682Humanized anti-human tumor necrosis factor alpha monoclonal antibody and sequence thereof
#11683Mice that make VL binding proteins
#11684ANTI-IL-6 ANTIBODIES,COMPOSITIONS, METHODS AND USES
#11685POLYPEPTIDES AND METHOD OF TREATMENT
#11686Antigen binding dimer-complexes, methods of making/avoiding and uses thereof
#11687Neutralizing molecules to viral antigens
#11688Human Oncostatin M Antibodies and Methods of Use
#11689Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof
#11690Monoclonal antibodies to proprotein convertase subtilisin kexin type 9 (PCSK9)
#11691Anti Notch-1 antibodies
#11692ANTI-VEGF-D ANTIBODIES
#11693Monoclonal antibody capable of binding to specific discontinuous epitope occurring in AD1 region of human cytomegalovirus GB glycoprotein, and antigen-binding fragment thereof
#11694HUMANIZED PCRV ANTIBODY HAVING ANTI-PSEUDOMONAL ACTIVITY
#11695Anti-CD27 humanized monoclonal antibody
#11696CHICKEN-DERIVED ANTI-LOX-1 ANTIBODY
#11697Methods for treating bone loss with antibodies to OPGL
#11698LOX AND LOXL2 INHIBITORS AND USES THEREOF
#11699TREATMENT METHODS USING DKK-1 ANTIBODIES
#11700Human anti-tau antibodies